This study was later extended to humans, Kootte found at 6 weeks after lean donor (allogenic) fecal microbiota transplantation, insulin sensitivity of recipients with the metabolic syndrome was significantly improved, accompanied by altered microbiota composition. The gene discussed is INS; the disease is metabolic syndrome.